Skip to Main Content

Paper Details

Novel Pharmacological Therapies for the Management of Hyperlipoproteinemia(a).
1
2023
CETP, CVD, Hyperlipoproteinemia(a), LPA, LPA gene variants, LY3819469, Lipoprotein(a), Lp, Lp(a), N-acetylgalactosamine, PCSK, PCSK-9, Pelacarsen, RNA agents, SLN360, abdominal aortic aneurysm, aortic valve calcification, apo, apo(a), apolipoprotein(a), aspirin, cardiovascular disease, coronary heart disease, estrogens, ezetimibe, hepatocytes, lipoprotein molecules, mipomersen, niacin, olpasiran, serum Lp(a), small interfering RNAs, statins, stroke
Author NameAffiliation
Loukianos S RallidisNational and Kapodistrian University of Athens, University General Hospital ATTIKON
  • 1 - 1

Datasets

Release 1.2